Cargando…
Immunosuppression and SARS-CoV-2 breakthrough infections
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054102/ https://www.ncbi.nlm.nih.gov/pubmed/35527809 http://dx.doi.org/10.1016/S2665-9913(22)00127-8 |
_version_ | 1784697120000835584 |
---|---|
author | Kim, Alfred H J Sparks, Jeffrey A |
author_facet | Kim, Alfred H J Sparks, Jeffrey A |
author_sort | Kim, Alfred H J |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9054102 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90541022022-05-02 Immunosuppression and SARS-CoV-2 breakthrough infections Kim, Alfred H J Sparks, Jeffrey A Lancet Rheumatol Comment Elsevier Ltd. 2022-06 2022-04-29 /pmc/articles/PMC9054102/ /pubmed/35527809 http://dx.doi.org/10.1016/S2665-9913(22)00127-8 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Comment Kim, Alfred H J Sparks, Jeffrey A Immunosuppression and SARS-CoV-2 breakthrough infections |
title | Immunosuppression and SARS-CoV-2 breakthrough infections |
title_full | Immunosuppression and SARS-CoV-2 breakthrough infections |
title_fullStr | Immunosuppression and SARS-CoV-2 breakthrough infections |
title_full_unstemmed | Immunosuppression and SARS-CoV-2 breakthrough infections |
title_short | Immunosuppression and SARS-CoV-2 breakthrough infections |
title_sort | immunosuppression and sars-cov-2 breakthrough infections |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054102/ https://www.ncbi.nlm.nih.gov/pubmed/35527809 http://dx.doi.org/10.1016/S2665-9913(22)00127-8 |
work_keys_str_mv | AT kimalfredhj immunosuppressionandsarscov2breakthroughinfections AT sparksjeffreya immunosuppressionandsarscov2breakthroughinfections |